Regulatory PathRegulatory requirements compared

Active substance

Idoxuridine

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
COLIRCUSI VIRUCIDE 0.2%0.2 %Eye drops · Ocular use1 Dropper ContainerSAR 9.70NCE · PrescriptionALCON CUSIWithdrawn by MAH · Not Marketed

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
HERPLEX0.1%solution/drops · ophthalmicALLERGANDiscontinued11 Jun 1963
DENDRID0.1%solution/drops · ophthalmicALCONDiscontinued28 Jun 1963
STOXIL0.1%solution/drops · ophthalmicGLAXOSMITHKLINEDiscontinued6 Apr 1964
STOXIL0.5%ointment · ophthalmicGLAXOSMITHKLINEDiscontinued2 Sep 1967

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.